METASTATIC LUNG NEUROENDOCRINE NEOPLASM
Clinical trials for METASTATIC LUNG NEUROENDOCRINE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new METASTATIC LUNG NEUROENDOCRINE NEOPLASM trials appear
Sign up with your email to follow new studies for METASTATIC LUNG NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for neuroendocrine tumors: cabozantinib shows promise in Late-Stage trial
Disease control OngoingThis phase 3 study tests the drug cabozantinib against a placebo in 298 people with advanced neuroendocrine tumors (including carcinoid tumors) that have worsened after prior treatment. Cabozantinib is a targeted therapy that may slow or stop tumor growth by blocking certain prot…
Matched conditions: METASTATIC LUNG NEUROENDOCRINE NEOPLASM
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New drug combo aims to boost radiation for brain tumors from lung cancer
Symptom relief OngoingThis early-phase trial tests a drug called berzosertib combined with whole brain radiation for people with lung cancer that has spread to the brain. The main goal is to find the safest dose and check for side effects. About 15 adults with non-small cell, small cell, or neuroendoc…
Matched conditions: METASTATIC LUNG NEUROENDOCRINE NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated May 26, 2026 09:52 UTC